In 2018, Med Learning Group (MLG) launched the THRIVE initiative, a large-scale, multi-faceted continuing medical education series in glycemic control that incorporates a variety of live and online educational activities/tools for enriched comprehension and engagement. This programming included partners such as ADA chapters, AAFP, Pack Health, Health Resources and Services Administration, Public Health Foundation, and the Hypoglycemia Support Foundation to further enhance content and offer an opportunity for long lasting impact on diabetes care. The series launched 3 national summit meetings with expert and local faculty and 25 grand rounds with chart audits in community-based practices/hospitals throughout the country showing improvements in both knowledge and competence. An online enduring program was created to further extend the impact. THRIVE includes unique and innovative tools to enhance the learning experience, facilitate continuous learning and translation into practice, and encourage patient education and dialogue. These included:

App/Mobile website: Features quickly downloadable materials and links to published articles and patient and provider tool kits.

iPads: Facilitate Q and A during live sessions and allow participants to engage in the lecture.

ADA materials: Provided local patient support information to participants.

Chart Audit: Occurred in institutions to identify gaps in care and highlighted change.

Personalized Posters: Choose a variety of images to design unique office posters.

Health advisors: Pack Health provided patients personalized health coaching.

The combination of advanced technology, diverse partnerships, and variety of educational channels ensures a robust delivery and distribution network. CME can advance the conversion of knowledge into practice while also having a visible impact on HCP-patient dialogue. THRIVE outcomes demonstrate how CME creates space for collaboration and partnership among HCPs, patients, and support groups.


C. Hosmer-Gallo: None. L.K. Welch: None. B. Hefele: None.


Novo Nordisk

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at